MONTREAL, Jan. 23, 2025 (GLOBE NEWSWIRE) -- (TSX: TLG; OTCQX: CHXMF; FRA: CM5R) (“Troilus” or the “Company”), reports that it has expanded its engineering team with three key appointments, further ...
We are committed to helping employees and teams at ETH Zurich to fully exploit their potential and hence provide high performance within our organization.
Revidia Therapeutics Inc., a cardiac regenerative medicine company developing first-in-class small molecule drug therapies for heart injury, has announced that it has expanded its leadership team in ...